U.S. markets closed
  • S&P Futures

    3,794.50
    +4.00 (+0.11%)
     
  • Dow Futures

    30,819.00
    -9.00 (-0.03%)
     
  • Nasdaq Futures

    13,036.00
    +50.50 (+0.39%)
     
  • Russell 2000 Futures

    2,141.60
    -5.70 (-0.27%)
     
  • Crude Oil

    53.38
    +0.40 (+0.76%)
     
  • Gold

    1,848.50
    +8.30 (+0.45%)
     
  • Silver

    25.48
    +0.16 (+0.63%)
     
  • EUR/USD

    1.2148
    +0.0015 (+0.12%)
     
  • 10-Yr Bond

    1.0920
    -0.0050 (-0.46%)
     
  • Vix

    23.24
    -1.10 (-4.52%)
     
  • GBP/USD

    1.3652
    +0.0017 (+0.13%)
     
  • USD/JPY

    103.7790
    -0.1130 (-0.11%)
     
  • BTC-USD

    35,662.02
    -573.21 (-1.58%)
     
  • CMC Crypto 200

    708.70
    -6.49 (-0.91%)
     
  • FTSE 100

    6,712.95
    -7.70 (-0.11%)
     
  • Nikkei 225

    28,504.38
    -129.08 (-0.45%)
     

Semi-annual Update on the AIR LIQUIDE Liquidity Contract

·2 min read

Regulatory News:

Under the liquidity contract entered into between AIR LIQUIDE (Paris:AI) and EXANE BNP PARIBAS, the following resources were listed in the liquidity account on December 31, 2020 (trading date):

  • 11,000 AIR LIQUIDE shares

  • 15,320,212 €

During the second half of 2020, a total of:

Purchase : 305,550 shares (2,314 transactions) 41,436,513 €
Sale : 304,934 shares (2,633 transactions) 41,454,379 €

It is reminded that:

As at June 30, 2020, the most recent update, the following resources had been allocated to the liquidity account:

  • 14,884 AIR LIQUIDE shares

  • 14,706,943 €

Purchase : 394,728 shares (2,590 transactions) 48,197,092 €
Sale : 386,594 shares (2,573 transactions) 47,408,547 €

As at December 31, 2018, the date of implementation of AMF Decision 2018-1 of July 2, 2018, the following resources had been allocated to the liquidity account:

  • 9,500 AIR LIQUIDE shares

  • 14,986,662 €

A world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 80 countries with approximately 67,000 employees and serves more than 3.7 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the company’s activities since its creation in 1902.
Air Liquide’s ambition is to be a leader in its industry, deliver long term performance and contribute to sustainability. The company’s customer-centric transformation strategy aims at profitable growth over the long term. It relies on operational excellence, selective investments, open innovation and a network organization implemented by the Group worldwide. Through the commitment and inventiveness of its people, Air Liquide leverages energy and environment transition, changes in healthcare and digitization, and delivers greater value to all its stakeholders.
Air Liquide’s revenue amounted to 22 billion euros in 2019 and its solutions that protect life and the environment represented more than 40% of sales. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, EURO STOXX 50 and FTSE4Good indexes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210114005456/en/

Contacts

Corporate Communications
Alexandra Rocca
+33 (0)1 40 62 50 93
Annie Fournier
+33 (0)1 40 62 57 18

Investor Relations
Aude Rodriguez
+33 (0)1 40 62 57 08
Muriel Legeron
+33 (0)1 40 62 50 18
Ludmilla Binet
+33 (0)1 40 62 57 37

Shareholder Services
Patrick Renard
+33 (0)1 40 62 51 86
Marie Lapierre
+33 (0)1 40 62 55 72